TishiS(Jha)ShahMD

PubMed

• Practice Variations in Managing Infantile Hemangiomas.
  Thomas W McLean, Alexandra J Borst, Adrienne M Hammill, Ionela Iacobas, Autumn Atkinson, Tishi Shah, Judith F Margolin, Sherry L Bayliff, Julie Blatt> ;Journal of Pediatric Hematology/oncology. 2023 Nov 1
• 4 citations
  Obinutuzumab (GA101) vs. rituximab significantly enhances cell death, antibody-dependent cytotoxicity and improves overall survival against CD20+ primary mediastinal B...
  Yaya Chu, Aradhana Awasthi, Sanghoon Lee, Dina Edani, Changhong Yin, Jessica Hochberg, Tishi Shah, Tae-Hoon Chung, Janet Ayello, Carmella van de Ven, Christian Klein, ...> ;Oncotarget. 2020 Aug 11
• 14 citations
  Ibrutinib significantly inhibited Bruton's tyrosine kinase (BTK) phosphorylation,in-vitro proliferation and enhanced overall survival in a preclinical Burkitt lymphoma...
  Yaya Chu, Sanghoon Lee, Tishi Shah, Changhong Yin, Matthew J. Barth, Rodney R. Miles, Janet Ayello, Erin Morris, Lauren Harrison, Carmella van de Ven, Paul J. Galardy,...> ;Oncoimmunology. 2019 Jan 1
• 15 citations
  Ruxolitinib significantly enhances in vitro apoptosis in Hodgkin lymphoma and primary mediastinal B-cell lymphoma and survival in a lymphoma xenograft murine model.
  Sanghoon Lee, Tishi Shah, Changhong Yin, Jessica Hochberg, Janet Ayello, Erin Morris, Carmella van de Ven, Mitchell S. Cairo> ;Oncotarget. 2018 Jan 18
• 29 citations
  The effects of DLEU1 gene expression in Burkitt lymphoma (BL): potential mechanism of chemoimmunotherapy resistance in BL.
  Sanghoon Lee, Wen Luo, Tishi Shah, Changhong Yin, Timmy O'Connell, Tae-Hoon Chung, Sherrie L. Perkins, Rodney R. Miles, Janet Ayello, Erin Morris, Lauren Harrison, Car...> ;Oncotarget. 2017 Feb 25
• Join now to see all